Loading...
RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.
Highlights

A collection of news and information related to Merck & Company Incorporated published by this site and its partners.

Sort By: Relevancy | Date | Type
Displaying items 1-12 of 269
» View wsbtradio.com items only
    May 24, 2013 |Story| Reuters
  1. Boy Scouts of America votes to end ban on gay scouts

    GRAPEVINE, Texas (Reuters) - The Boy Scouts of America voted on Thursday to lift a century-old ban on openly gay scouts in a major victory for gay rights activists, but the decision means a sea of change for an organization that depends heavily on faith-based groups.
    Reuters
    GRAPEVINE, Texas (Reuters) - The Boy Scouts of America voted on Thursday to lift a century-old ban on openly gay scouts in a major victory for gay rights activists, but the decision means a sea of change for an organization that depends heavily on faith-...

    Tags: Social Organizations, Gays and Lesbians, Elections, Politics, Intel Corp.

  2. May 23, 2013 | Orlando Sentinel
  3. UCF trustees approve $1.4 billion operating budget that includes no tuition increase

    Sentinel School Zone
    Trustees at the University of Central Florida this afternoon approved a $1.4 billion operating budget for the coming school year that includes no tuition increase. But Chief Financial Officer Bill Merck explained that base undergraduate tuition for...

    Tags: Budgets and Budgeting, University of Central Florida, Education, Rick Scott, Colleges and Universities

  4. May 23, 2013 |Story| Reuters
  5. Merck halts development of experimental Parkinson's drug

    Reuters
    May 23 (Reuters) - Merck & Co has ended development of preladenant, an experimental drug for Parkinson's disease, after initial data from three late-stage trials proved disappointing. New Jersey-based Merck said the decision to discontinue the studies...

    Tags: Diseases and Illnesses, Parkinson's Disease, Medical Research, Science and Technology

  6. May 23, 2013 |Story| Reuters
  7. RPT-FEATURE-Pfizer takes its shot at a vaccine for evasive superbug

    Reuters
    By Julie Steenhuysen CHICAGO, May 23 (Reuters) - Kathrin Jansen is a microbiologist with at least two breakthrough vaccines to her name: she brought the cervical cancer vaccine Gardasil to market for Merck and helped develop the $4 billion a year...

    Tags: Staphylococcal Infection , Nabi, Health and Safety at School, Chemical Industry, Science and Technology

  8. May 20, 2013 |Story| Reuters
  9. WASIK COLUMN-Two ways to pick your summer stock retreat

    Reuters
    By John Wasik CHICAGO, May 20 (Reuters) - It used to be easy to abide by the old Wall Street nugget that you should pull out of the market in spring and come back in the fall. But research shows that it doesn't make sense to completely abandon the stock...

    Tags: Stock Market, S&P 500, Dwayne Johnson, International Paper Company, Google Inc.

  10. May 23, 2013 |Story| Reuters
  11. EUROPE RESEARCH ROUNDUP: ARM Holdings, Anglo American, Statoil, Bayer

    Reuters
    May 23 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Anglo American, Bayer and Thomas Cook Group, on Thursday. HIGHLIGHTS * ARM Holdings PLC : Exane BNP Paribas cuts to neutral from...

    Tags: SABMiller plc, Air France-KLM, Vodafone Group Plc, Weight, Mining

  12. May 22, 2013 |Story| Reuters
  13. FDA panel: Merck's insomnia drug effective, safe at low doses

    Reuters
    WASHINGTON, May 22 (Reuters) - Merck & Co's experimental insomnia drug is safe and effective at the lower of two doses studied but not at the higher, a panel of medical experts said on Wednesday. The panel, which advises the U.S. Food and Drug...

    Tags: Insomnia, Food and Drug Administration

  14. May 22, 2013 |Story| Reuters
  15. Merck's insomnia drug moves a step closer to U.S. approval

    Reuters
    WASHINGTON (Reuters) - Merck & Co's experimental insomnia drug moved a step closer to U.S. approval on Wednesday after a panel of medical experts said it is effective and safe at lower doses. The advisory panel was convened to help the U.S. Food and Drug...

    Tags: Insomnia, Drugs and Medicines, Trials, Car Safety Tips and Advice, Food and Drug Administration

  16. May 22, 2013 |Story| AP Broadcast
  17. FDA panel favors Merck sleeping aid despite safety concerns over drowsiness, driving issues

    AP Health Writer
    WASHINGTON (AP) — A federal panel of medical experts said that an experimental insomnia drug from Merck & Co. Inc. appears safe and effective, despite evidence from company trials that the pill can cause daytime sleepiness and difficulty driving. A...

    Tags: Insomnia, Drugs and Medicines, Car Safety Tips and Advice, Washington, DC, Food and Drug Administration

  18. May 22, 2013 |Story| Reuters
  19. Indian stocks to watch-May 23

    Reuters
    May 23 (Reuters) - GLOBAL MARKETS ROUNDUP * Nifty futures on the Singapore Exchange are 0.5 percent down and the MSCI-Asia Pacific index excluding Japan is 1.5 percent lower. * Japanese government bond prices dived and 10-year JGB futures tumbled a full...

    Tags: Finance, Tokyo Stock Exchange, Economy, Business and Finance, Stock Market, Diabetes

  20. May 22, 2013 |Story| Los Angeles Times
  21. FDA panel backs a new sleep drug

    An advisory panel to the Food & Drug Administration has recommended approval of a new sleep drug that targets the brain's wakefulness centers, but suggested the agency should consider a dose of the drug,  called suvorexant, lower  than that proposed by the medication's maker, Merck. In doing so, members of the FDA's advisory committee on peripheral and central nervous system drugs appeared to agree with concerns raised by FDA staff scientists that, at higher doses, the sleep medication may cause dangerous next-day drowsiness in some patients.
    An advisory panel to the Food & Drug Administration has recommended approval of a new sleep drug that targets the brain's wakefulness centers, but suggested the agency should consider a dose of the drug,  called suvorexant, lower  than that proposed by...

    Tags: Insomnia, Trials, Food and Drug Administration, Elections, Pharmaceuticals

  22. May 22, 2013 |Story| Reuters
  23. Merck anuncia acuerdo de recompra acciones por 5.000 mln dlrs con Goldman Sachs

    Reuters
    21 mayo (Reuters) - Merck & Co Inc dijo que entró en un acuerdo de recompra de acciones por 5.000 millones de dólares con Goldman Sachs Group Inc, en momentos en que el gigante farmacéutico busca apuntalar el valor de los accionistas frente a la dura...

    Tags: Goldman Sachs Group, Inc.

 1  2 3 4 5 6 7 8 9 10 11-23Next >
Original site for Merck & Company Incorporated topic gallery.
Loading...
 
 

Date:

Credit:

User-submitted

Tags:

Rate:
Sending...

E-mail this photo

Error: malformed email address(es)
Both "from" and "recipient" email fields are required.

Recipient E-mail Addresses

(up to 3, separated by commas) Send me a copy.

From:

e-mail | buy this photo | link to photo
Merck & Company Incorporated Photos
This undated image provided by Merck & Co., shows a cro...
(December 12, 2012)
AP Photo/Merck & Co.
Ivy Merck was last seen in Kingsland, Ga., but her Hond...
(August 30, 2012)
Ivy Merck
Mick Jagger and Keith Richards perform at the Ernst-Mer...
(July 12, 2012)
The Rolling Stones 50 years